BEHANDLUNG METASTASIERTER TUMORE

Patent europeic · EP1845990 · Stritgà

Inscripziun en il register

Numer da publicaziun: EP1845990
Numer da la dumonda: EP06733986
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: Stritgà
Scrittira da patent: Concedì
Annunzià: 27-01-2006
Publitgà: 24-10-2007
Concedì: 28-09-2011
Stritgà: 31-01-2016
Motiv: Taxa annuala betg pajada
Classas IPC: A61K 31/497 (2006.01)
A61P 35/00 (2006.01)
Prioritad: US 647568 P 27.01.2005
US 669245 P 06.04.2005
US 722053 P 29.09.2005
Dumonda PCT: PCT/US2006/002979 27.01.2006
Publicaziun PCT: WO2006/081445 03.08.2006
Lingua da l’annunzia: englais
Funtauna: Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

24-08-2016
Stritgà, taxa betg pajada
Published in Swissreg on 24.08.2016
28-09-2011
Concedì
Published in Swissreg on 28.09.2011

Partidas

Possessur

Novartis Vaccines and Diagnostics, Inc.

Intellectual Property - R440 P.O. Box 8097, Emeryville, CA 94662-8097, US

Inventur

LOPES DE MENEZES, Daniel, c/o Chiron Corporation

Emeryville, CA 94662-8097, US

HEISE, Carla, c/o Chiron Corporation

Emeryville, CA 94662-8097, US

XIN, Xiaohua, c/o Chiron Corporation

Emeryville, CA 94662-8097, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.